Adams Street Closes $2.5B Co-Investment Fund as LP Appetite Soars

Adams Street Partners just raised $2.5 billion for its sixth co-investment fund—a 47% increase from the $1.7 billion it closed three years ago. The number itself is notable. The velocity behind it is more so.

Co-investment vehicles, which allow limited partners to invest directly alongside general partners in individual deals without paying the usual management fees or carried interest, have gone from niche allocation strategy to core portfolio infrastructure. For institutions trying to boost net returns in an environment where traditional PE fees remain stubbornly high, co-invest has become less optional.

Adams Street's latest fund, which the firm disclosed April 22, comes at a moment when institutional investors are rethinking how much capital should flow through traditional fund structures versus direct or co-investment vehicles. The question isn't whether to co-invest anymore—it's how much, how fast, and with whom.

The Chicago-based firm, which manages approximately $60 billion globally, has been building co-investment capabilities for more than two decades. But the scale and pace of recent fundraising suggest something structural has shifted. LPs aren't just diversifying. They're building parallel portfolios.

The appeal of co-investment has always been straightforward: lower fees, more control, and the ability to concentrate capital in deals an LP already has conviction around. But three forces have converged to make co-invest vehicles more central to institutional strategy in 2025.

First, fee pressure. Public pension funds and endowments have spent the last five years publicly challenging the 2-and-20 model, but management fees on private equity funds have barely budged. Co-investment offers a structural workaround—direct exposure to deals without the fee layer.

Second, capital concentration. As mega-funds have grown larger, LPs are finding that their commitments get diluted across dozens of portfolio companies. Co-invest lets them double down on the deals they like most, effectively building a custom portfolio within the broader fund relationship.

Third, operational maturity. A decade ago, most institutional LPs didn't have the internal resources to evaluate co-investment opportunities quickly. Today, many have built dedicated teams capable of underwriting deals on compressed timelines—often within days. That capability has turned co-invest from aspirational to executable.

Adams Street isn't the only firm raising dedicated co-investment funds—Lexington Partners, Hamilton Lane, and StepStone all run similar vehicles. But its approach sits somewhere between pure co-GP model and fully discretionary fund.

The firm sources co-investment opportunities primarily from its network of over 500 GP relationships globally, spanning venture, growth, buyout, and secondaries. LPs in the co-investment fund get access to deals Adams Street has already underwritten through its primary fund commitments—effectively piggybacking on relationships and diligence the firm has spent decades building.

That network effect matters because co-investment deal flow isn't evenly distributed. Top-tier GPs tend to offer co-invest opportunities selectively, often to their longest-standing LPs or those who can move capital quickly. Adams Street's positioning as both a large LP and a co-investment manager gives it access that standalone institutional investors often can't replicate on their own.

The table above shows consistent step-up growth over three consecutive funds—a pattern that suggests LP demand isn't cyclical, it's structural. Even as broader private equity fundraising has slowed in the past 18 months, co-investment vehicles have remained oversubscribed.

Adams Street's co-investment fund is sector-agnostic and globally diversified, which gives LPs exposure across technology, healthcare, industrials, and consumer verticals without forcing sector bets upfront. That flexibility is intentional—it mirrors how the firm's LP base thinks about portfolio construction.

Co-investment isn't free money. It comes with trade-offs that institutional investors are increasingly willing to accept but shouldn't ignore.

The first is selection risk. GPs typically offer co-investment opportunities when they need additional capital to complete a deal—which can mean the deal is larger, more competitive, or requires more equity than the fund alone can provide. That doesn't make it a worse investment, but it does mean the GP is offloading some capital risk.

Some LPs worry about adverse selection—the possibility that GPs reserve their highest-conviction deals for their own funds and offer co-invest on everything else. There's no industry-wide data to prove or disprove this, but the concern is real enough that sophisticated LPs now track co-invest performance separately and compare it to the GP's flagship fund returns.

The second trade-off is operational burden. Even when working with a co-investment manager like Adams Street, LPs still need to review deal memos, sign off on investments, and monitor performance across a portfolio that can quickly grow to dozens of individual companies. That requires staff, systems, and speed.

The math on fee savings is straightforward in theory: co-investments typically carry no management fee and reduced or zero carried interest. For a $100 million co-investment that returns 3x over five years, the LP saves roughly $2 million in management fees and another $20-40 million in carry compared to the same investment made through a traditional fund structure.

But that assumes the co-investment performs as well as the fund. If the deal underperforms—or if the LP misses out on the fund's best-performing companies by concentrating too much capital in co-invest—the fee savings become irrelevant. The real value of co-investment comes from selectivity, not just fee arbitrage.

The size of Adams Street's latest fund—and the speed with which it was raised—reflects a broader recalibration happening inside institutional investment offices. LPs are no longer treating co-investment as a side allocation or opportunistic add-on. It's becoming a permanent, scaled component of private markets exposure.

For many institutions, that means setting explicit co-investment targets: 10-20% of total private equity exposure, deployed through a mix of direct co-investments and dedicated co-investment funds. Those targets didn't exist five years ago. Now they're appearing in investment policy statements.

It also reflects growing comfort with the idea that not all private equity exposure needs to come through traditional fund commitments. LPs are building multi-layered strategies: core fund commitments for diversification and GP relationships, co-investment for fee mitigation and concentration, and secondaries for liquidity management.

Adams Street's fundraising success suggests that LPs see value in outsourcing some of that co-investment work to specialists who can source, underwrite, and manage deal flow at scale. Not every institution has the resources to build that capability internally—but they all want the exposure.

Adams Street now competes in a co-investment market that includes firms like Hamilton Lane (which manages over $15 billion in co-investment AUM), Lexington Partners (which has raised multiple multi-billion-dollar co-investment funds), and StepStone (which integrates co-invest across its platform). The market is large enough to support multiple scaled players, but concentrated enough that reputation and deal access matter.

What differentiates firms in this market isn't just capital—it's speed, selectivity, and the ability to add value beyond check-writing. LPs want co-investment managers who can underwrite quickly, negotiate favorable terms, and provide portfolio support when deals need operational help. That's a harder capability to replicate than just raising a big fund.

The rise of co-investment is also changing how GPs think about deal structure and LP relationships. As more capital flows into co-investment vehicles, GPs are offering co-invest opportunities earlier in the fundraising cycle and to a broader set of LPs—not just their largest or longest-tenured partners.

Some GPs now build co-investment expectations into their fund economics from the start, sizing flagship funds with the assumption that 20-30% of deal equity will come from LP co-investment. That shifts the GP's role from sole capital provider to capital coordinator—and changes the economics of fund management.

For LPs, that creates both opportunity and risk. More co-investment deal flow is good. But if GPs are structurally relying on co-invest to close deals, it raises questions about whether the flagship fund is properly sized—and whether LPs are effectively subsidizing undersized fund commitments.

If Adams Street's fundraising trajectory holds—and there's little reason to think it won't—the firm's seventh co-investment fund could target $3.5-4 billion when it launches in 2027 or 2028. That would put it in the same scale tier as some mid-sized buyout funds, a striking evolution for what was once a niche allocation strategy.

The broader co-investment market is projected to exceed $100 billion in annual deployment by 2026, according to data from Preqin and PitchBook. That figure includes both dedicated co-investment funds and direct LP co-investments, but the growth rate is consistent across both categories.

The data above underscores a trend: co-investment isn't replacing traditional PE funds, but it's growing faster. And as more capital flows into the strategy, the firms that can deliver consistent access and performance will continue to raise larger vehicles.

For LPs, the challenge will be maintaining discipline. Co-investment works when it's selective—when LPs are doubling down on their highest-conviction opportunities. If it becomes a default allocation or a way to deploy capital quickly without rigorous underwriting, the fee savings won't matter. The returns will suffer.

Adams Street's $2.5 billion raise is a data point, not an anomaly. It reflects institutional investors making a structural bet that co-investment will remain a core part of their private markets strategy for the next decade.

That bet assumes three things continue to hold true: GPs keep offering co-investment opportunities at scale, LPs maintain the internal capacity to evaluate deals quickly, and co-investment performance remains competitive with flagship fund returns. If any of those assumptions break, the strategy will need recalibration.

But for now, the momentum is clear. LPs want more control, lower fees, and the ability to concentrate capital in deals they've already underwritten through their fund commitments. Co-investment delivers all three—and firms like Adams Street are building the infrastructure to deliver it at scale.

The question isn't whether co-investment will keep growing. It's whether the firms raising these vehicles can maintain the selectivity and performance discipline that made the strategy attractive in the first place. Adams Street's track record suggests it can. The next few years will show whether the rest of the market can keep up.

One risk that hasn't fully surfaced: What happens when co-investment becomes so popular that deal flow becomes constrained? If every large LP wants to co-invest in every top-tier deal, GPs will face allocation pressures that could strain relationships—or lead to co-investment opportunities being rationed to only the largest, stickiest LPs.

That would create a two-tier system where the most sophisticated, best-capitalized institutions get first access to co-invest opportunities, and everyone else is left deploying capital through traditional funds. It's already happening in venture, where A-list GPs can cherry-pick their co-investors. It's starting to happen in buyout too.

Another underappreciated risk is performance dispersion. Co-investment returns are inherently more volatile than diversified fund returns because LPs are concentrating capital in individual deals. A few bad picks can destroy years of fee savings. That volatility is manageable when markets are strong and exits are flowing. It's less manageable when liquidity dries up and portfolio companies underperform.

LPs who've built co-investment allocations rapidly over the past five years haven't yet weathered a full down-cycle with those portfolios. The real test of co-investment as a strategy will come when exits stall, valuations compress, and the deals that looked obvious in 2023 turn out to have been mispriced. That hasn't happened yet. But it will.